rs750907713
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1
The ENST00000638452.2(ENSG00000283782):c.1A>G(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.000018 in 1,607,662 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★★). Synonymous variant affecting the same amino acid position has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000638452.2 start_lost
Scores
Clinical Significance
Conservation
Publications
- Nijmegen breakage syndrome-like disorderInheritance: AR Classification: STRONG, LIMITED Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: ENST00000638452.2. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| RAD50 | NM_005732.4 | MANE Select | c.298A>G | p.Met100Val | missense | Exon 3 of 25 | NP_005723.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ENSG00000283782 | ENST00000638452.2 | TSL:5 | c.1A>G | p.Met1? | start_lost | Exon 5 of 27 | ENSP00000492349.2 | ||
| RAD50 | ENST00000416135.5 | TSL:1 | c.1A>G | p.Met1? | start_lost | Exon 3 of 5 | ENSP00000389515.1 | ||
| RAD50 | ENST00000378823.8 | TSL:1 MANE Select | c.298A>G | p.Met100Val | missense | Exon 3 of 25 | ENSP00000368100.4 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000279 AC: 7AN: 251334 AF XY: 0.0000442 show subpopulations
GnomAD4 exome AF: 0.0000192 AC: 28AN: 1455462Hom.: 0 Cov.: 31 AF XY: 0.0000276 AC XY: 20AN XY: 724480 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152200Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74356 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Hereditary cancer-predisposing syndrome Uncertain:2
The p.M100V variant (also known as c.298A>G), located in coding exon 3 of the RAD50 gene, results from an A to G substitution at nucleotide position 298. The methionine at codon 100 is replaced by valine, an amino acid with highly similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
This sequence change replaces methionine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 100 of the RAD50 protein (p.Met100Val). This variant is present in population databases (rs750907713, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with RAD50-related conditions. ClinVar contains an entry for this variant (Variation ID: 457426). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt RAD50 protein function with a negative predictive value of 80%. RNA analysis performed to evaluate the impact of this missense change on mRNA splicing indicates it does not significantly alter splicing (Invitae). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at